Invention Grant
US09273143B2 Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody
有权
包含抗ErbB3抗体和抗EGFR抗体的组合的方法和组合物
- Patent Title: Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EGFR antibody
- Patent Title (中): 包含抗ErbB3抗体和抗EGFR抗体的组合的方法和组合物
-
Application No.: US14082780Application Date: 2013-11-18
-
Publication No.: US09273143B2Publication Date: 2016-03-01
- Inventor: Christopher Daly , Douglas MacDonald , Xunbao Duan
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Alston & Bird LLP
- Agent Frank Cottingham; Anna Digabriele Petti
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; A61K39/00 ; A61K39/395 ; C07K16/32 ; C07K16/28
Abstract:
The present invention provides pharmaceutical compositions comprising an anti-ErbB3 antibody and an anti-EGFR antibody, and methods of use thereof. The compositions and methods of the present invention are useful for the treatment of various cancers and other diseases and disorders.
Public/Granted literature
- US20140072563A1 Methods and Compositions Comprising a Combination of an Anti-ErbB3 Antibody and an Anti-EGFR Antibody Public/Granted day:2014-03-13
Information query
